Sagimet Biosciences (SGMT) Equity Ratio: 2023-2024
Historic Equity Ratio for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to 0.98.
- Sagimet Biosciences' Equity Ratio rose 2.70% to 0.98 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.98, marking a year-over-year increase of 2.70%. This contributed to the annual value of 0.94 for FY2023, which is N/A change from last year.
- According to the latest figures from Q3 2024, Sagimet Biosciences' Equity Ratio is 0.98, which was up 0.71% from 0.97 recorded in Q2 2024.
- Sagimet Biosciences' 5-year Equity Ratio high stood at 0.98 for Q1 2024, and its period low was -9.23 during Q2 2023.
- Over the past 2 years, Sagimet Biosciences' median Equity Ratio value was 0.96 (recorded in 2023), while the average stood at -0.74.
- Data for Sagimet Biosciences' Equity Ratio shows a peak YoY soared of 110.51% (in 2024) over the last 5 years.
- Quarterly analysis of 2 years shows Sagimet Biosciences' Equity Ratio stood at 0.94 in 2023, then grew by 2.70% to 0.98 in 2024.
- Its Equity Ratio was 0.98 in Q3 2024, compared to 0.97 in Q2 2024 and 0.98 in Q1 2024.